Hepatic steatosis as an emerging cause of cirrhosis in HIV-infected patients

被引：17
|
作者：
Loulergue, Pierre [1 ]
Callard, Patrice
Bonnard, Philippe
Pialoux, Gilles
机构：
[1] Univ Paris 06, Serv Malad Infect, F-75252 Paris 05, France
[2] Univ Paris 06, Serv Anatomopathol, F-75252 Paris 05, France
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 45卷 / 03期
关键词：
D O I：
10.1097/QAI.0b013e318050d864
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [21] Metabolic acidosis and hepatic steatosis in two HIV-infected patients on Stavudine (d4T) treatment
    Cornejo-Juárez, P
    Sierra-Madero, J
    Volkow-Fernández, P
    ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (01) : 64 - 69
  • [22] Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection
    Vecchi, Valentina Li
    Soresi, Maurizio
    Giannitrapani, Lydia
    Di Carlo, Paola
    Mazzola, Giovanni
    Colletti, Pietro
    Terranova, Antonino
    Vizzini, Giovanni
    Montalto, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (05) : E397 - E402
  • [23] New and emerging agents in the management of lipodystrophy in HIV-infected patients
    Bonnet, Eric
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 167 - 178
  • [24] Thrombotic microangiopathy as a cause of dilated cardiomyopathy in HIV-infected patients
    Mayo, J
    Collazos, J
    Martínez, E
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2000, 32 (05) : 557 - 558
  • [25] Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients
    Praktiknjo, Michael
    Natalie, Djayadi
    Jenny, Bischoff
    Raphael, Mohr
    Schierwagen, Robert
    Pohlmann, Alessandra
    Schwarze-Zander, Carolynne
    Wasmuth, Jan-Christian
    Boesecke, Christoph
    Rockstroh, Juergen
    Trebicka, Jonel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E780 - E780
  • [26] Weight gain after switching to integrase inhibitor-based ART is not associated with hepatic steatosis in HIV-infected patients
    Gonzalez-Serna, A.
    Macias, J.
    Rincon, P.
    Arriaza, M. J.
    Corma-Gomez, A.
    Santos, M.
    Fernandez-Fuertes, M.
    Real, L. M.
    Pineda, J. A.
    HIV MEDICINE, 2021, 22 : 88 - 89
  • [27] Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients
    Praktiknjo, Michael
    Djayadi, Natalie
    Mohr, Raphael
    Schierwagen, Robert
    Bischoff, Jenny
    Dold, Leona
    Pohlmann, Alessandra
    Schwarze-Zander, Carolynne
    Wasmuth, Jan-Christian
    Boesecke, Christoph
    Rockstroh, Juergen K.
    Trebicka, Jonel
    LIVER INTERNATIONAL, 2019, 39 (08) : 1514 - 1520
  • [28] Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient
    Acosta, BS
    Grimsley, EW
    SOUTHERN MEDICAL JOURNAL, 1999, 92 (04) : 421 - 423
  • [29] HEPATIC ALTERATIONS IN HIV-INFECTED PATIENTS - 83 CASES REPORT
    BLANNO, VM
    VILLARREAL, C
    ROBLES, M
    TORRES, R
    CANO, C
    HEPATOLOGY, 1994, 19 (04) : I44 - I44
  • [30] HEPATOMEGALY AND STEATOSIS IN HIV-INFECTED PATIENTS RECEIVING NUCLEOSIDE ANALOG ANTIRETROVIRAL THERAPY
    FORTGANG, IS
    BELITSOS, PC
    CHAISSON, RE
    MOORE, RD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1995, 90 (09): : 1433 - 1436
12345